
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $413.8M | $379.4M | $252.1M | $220.2M | $193.2M | |
Revenue Growth (YoY) | 38% | -8.32% | -33.57% | -12.63% | -12.29% | |
Cost of Revenues | $363.1M | $528.9M | $300.1M | $160.3M | $136.1M | |
Gross Profit | $50.7M | -$149.5M | -$48.1M | $59.9M | $57.1M | |
Gross Profit Margin | 12.25% | -39.4% | -19.06% | 27.22% | 29.56% | |
R&D Expenses | $43.6M | $25.7M | $16.4M | $3.4M | -- | |
Selling, General & Admin | $396.6M | $288M | $225.4M | $133.9M | $87.4M | |
Other Inc / (Exp) | -$840.9M | $373.3M | -$2B | -$188.5M | -$333.8M | |
Operating Expenses | $494.4M | $359.8M | $251.3M | $154.8M | $104.8M | |
Operating Income | -$443.7M | -$509.3M | -$299.4M | -$94.8M | -$47.7M | |
Net Interest Expenses | -- | $77.6M | $77.1M | $66.1M | $47.2M | |
EBT. Incl. Unusual Items | -$1.3B | -$213.6M | -$2.3B | -$349.4M | -$428.7M | |
Earnings of Discontinued Ops. | -- | -$57.2M | -$173.3M | -$142.4M | $4.3M | |
Income Tax Expense | -$9.9M | -$7.1M | -$4.3M | $9.1M | $5.1M | |
Net Income to Company | -$1.3B | -$206.5M | -$2.3B | -$358.5M | -$433.8M | |
Minority Interest in Earnings | -$56.1M | $16.4M | $23.7M | $13.7M | -- | |
Net Income to Common Excl Extra Items | -$1.3B | -$247.3M | -$2.5B | -$487.2M | -$429.5M | |
Basic EPS (Cont. Ops) | -$35.50 | -$6.32 | -$53.47 | -$6.52 | -$3.99 | |
Diluted EPS (Cont. Ops) | -$35.50 | -$6.32 | -$53.47 | -$6.52 | -$3.99 | |
Weighted Average Basic Share | $37.2M | $39.1M | $46.4M | $74.8M | $107.6M | |
Weighted Average Diluted Share | $37.2M | $39.1M | $46.4M | $74.8M | $107.6M | |
EBITDA | -$1.2B | -$42.3M | -$2.2B | -$231.9M | -$344.2M | |
EBIT | -$1.3B | -$130.7M | -$2.2B | -$271.3M | -$375.2M | |
Revenue (Reported) | $413.8M | $379.4M | $252.1M | $220.2M | $193.2M | |
Operating Income (Reported) | -$443.7M | -$509.3M | -$299.4M | -$94.8M | -$47.7M | |
Operating Income (Adjusted) | -$1.3B | -$130.7M | -$2.2B | -$271.3M | -$375.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $117.1M | $53M | $50.4M | $54M | $45.2M | |
Revenue Growth (YoY) | 45.52% | -54.76% | -4.81% | 7.01% | -16.21% | |
Cost of Revenues | $109.4M | $174.2M | $98M | $42.5M | $37.9M | |
Gross Profit | $7.7M | -$121.2M | -$47.5M | $11.5M | $7.3M | |
Gross Profit Margin | 6.6% | -228.77% | -94.26% | 21.25% | 16.21% | |
R&D Expenses | $12.5M | $6.8M | $3.2M | $625K | -- | |
Selling, General & Admin | $102.5M | $38.8M | $59.9M | $31.2M | $6.1M | |
Other Inc / (Exp) | -$360.9M | -$217.3M | -$326.2M | -$33M | -$141.7M | |
Operating Expenses | $127.5M | $55.1M | $52.8M | $35.8M | $10.4M | |
Operating Income | -$119.8M | -$176.3M | -$100.4M | -$24.3M | -$3.1M | |
Net Interest Expenses | $1.9M | $21.1M | $20.1M | $13.9M | $9M | |
EBT. Incl. Unusual Items | -$482.7M | -$414.6M | -$446.7M | -$71.3M | -$153.8M | |
Earnings of Discontinued Ops. | -- | -- | -$44.1M | $1.7M | $495.8K | |
Income Tax Expense | $3.9M | -$6.7M | $3.6M | -$1.1M | $228.8K | |
Net Income to Company | -$456M | -$411.3M | -$495M | -$72.7M | -$161.3M | |
Minority Interest in Earnings | -$65.7M | $4.9M | $5.6M | -- | -- | |
Net Income to Common Excl Extra Items | -$552.3M | -$459.6M | -$473.1M | -$68.5M | -$153.5M | |
Basic EPS (Cont. Ops) | -$14.60 | -$11.52 | -$9.46 | -$0.53 | -$0.99 | |
Diluted EPS (Cont. Ops) | -$14.60 | -$11.52 | -$9.46 | -$0.53 | -$0.99 | |
Weighted Average Basic Share | $37.8M | $39.4M | $49.5M | $89.4M | $153.7M | |
Weighted Average Diluted Share | $37.8M | $39.4M | $49.5M | $89.4M | $153.7M | |
EBITDA | -$456.1M | -$372.6M | -$406.2M | -$47.2M | -$135.1M | |
EBIT | -$478.9M | -$393.9M | -$420.4M | -$55.6M | -$143.1M | |
Revenue (Reported) | $117.1M | $53M | $50.4M | $54M | $45.2M | |
Operating Income (Reported) | -$119.8M | -$176.3M | -$100.4M | -$24.3M | -$3.1M | |
Operating Income (Adjusted) | -$478.9M | -$393.9M | -$420.4M | -$55.6M | -$143.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $415.3M | $380M | $263.1M | $220.2M | $193M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $364.4M | $527.5M | $311.7M | $160.3M | $135.7M | |
Gross Profit | $50.9M | -$147.5M | -$48.5M | $59.9M | $57.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $43.7M | $25.7M | $16.5M | -- | -- | |
Selling, General & Admin | $396.4M | $288.4M | $237.6M | $133.8M | $88M | |
Other Inc / (Exp) | -$863.8M | $383.2M | -$2B | -$187.5M | -$331.1M | |
Operating Expenses | $494.2M | $360.2M | $264.7M | $154.8M | $105.4M | |
Operating Income | -$443.3M | -$507.6M | -$313.2M | -$94.9M | -$48M | |
Net Interest Expenses | -- | $77.6M | $76.9M | $66.1M | $47.4M | |
EBT. Incl. Unusual Items | -$1.3B | -$202M | -$2.4B | -$348.4M | -$426.5M | |
Earnings of Discontinued Ops. | -- | -- | -$155.4M | -$143.2M | $4.4M | |
Income Tax Expense | -$9.8M | -$7M | $13.8M | $9.2M | $5.2M | |
Net Income to Company | -$1.3B | -$206.5M | -$2.3B | -$358.5M | -$433.8M | |
Minority Interest in Earnings | -$60.7M | $16.3M | $23.8M | $13.8M | -- | |
Net Income to Common Excl Extra Items | -$1.3B | -$235.3M | -$2.5B | -$487.1M | -$427.3M | |
Basic EPS (Cont. Ops) | -$36.08 | -$5.67 | -$59.15 | -$6.19 | -$4.04 | |
Diluted EPS (Cont. Ops) | -$36.08 | -$7.14 | -$59.15 | -$6.19 | -$4.04 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$1.2B | -$30.7M | -$2.2B | -$230.9M | -$341.8M | |
EBIT | -$1.3B | -$119.2M | -$2.3B | -$270.3M | -$372.8M | |
Revenue (Reported) | $415.3M | $380M | $263.1M | $220.2M | $193M | |
Operating Income (Reported) | -$443.3M | -$507.6M | -$313.2M | -$94.9M | -$48M | |
Operating Income (Adjusted) | -$1.3B | -$119.2M | -$2.3B | -$270.3M | -$372.8M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $380M | $263.1M | $220.2M | $193M | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $527.5M | $311.7M | $160.3M | $135.7M | -- | |
Gross Profit | -$147.5M | -$48.5M | $59.9M | $57.3M | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $25.7M | $16.5M | $1.6M | -- | -- | |
Selling, General & Admin | $288.4M | $237.6M | $133.8M | $88M | -- | |
Other Inc / (Exp) | $383.2M | -$2B | -$187.5M | -$331.1M | -- | |
Operating Expenses | $360.2M | $264.7M | $154.8M | $105.4M | -- | |
Operating Income | -$507.6M | -$313.2M | -$94.9M | -$48M | -- | |
Net Interest Expenses | $77.6M | $76.9M | $66.1M | $47.4M | -- | |
EBT. Incl. Unusual Items | -$202M | -$2.4B | -$348.4M | -$426.5M | -- | |
Earnings of Discontinued Ops. | -- | -$155.4M | -$143.2M | $4.4M | -- | |
Income Tax Expense | -$7M | $13.8M | $9.2M | $5.2M | -- | |
Net Income to Company | -$206.5M | -$2.3B | -$358.5M | -$433.8M | -- | |
Minority Interest in Earnings | $16.3M | $23.8M | $13.8M | -- | -- | |
Net Income to Common Excl Extra Items | -$235.3M | -$2.5B | -$487.1M | -$427.3M | -- | |
Basic EPS (Cont. Ops) | -$5.67 | -$59.15 | -$6.19 | -$4.04 | -- | |
Diluted EPS (Cont. Ops) | -$7.14 | -$59.15 | -$6.19 | -$4.04 | -- | |
Weighted Average Basic Share | $156.5M | $185.1M | $299M | $430.1M | -- | |
Weighted Average Diluted Share | $158.6M | $185.1M | $299M | $430.1M | -- | |
EBITDA | -$30.7M | -$2.2B | -$230.9M | -$341.8M | -- | |
EBIT | -$119.2M | -$2.3B | -$270.3M | -$372.8M | -- | |
Revenue (Reported) | $380M | $263.1M | $220.2M | $193M | -- | |
Operating Income (Reported) | -$507.6M | -$313.2M | -$94.9M | -$48M | -- | |
Operating Income (Adjusted) | -$119.2M | -$2.3B | -$270.3M | -$372.8M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $914.7M | $621.6M | $493.6M | $126M | $79.5M | |
Short Term Investments | $906.7M | $477.1M | $78M | $24.5M | $12.3M | |
Accounts Receivable, Net | $53.2M | $54.6M | $30.5M | $33.3M | $33.2M | |
Inventory | $291.5M | $163.8M | $61.5M | $57.2M | $67.3M | |
Prepaid Expenses | $38.2M | $26.9M | $10.5M | $6.7M | $3.9M | |
Other Current Assets | $15.1M | $15.3M | $7.5M | $10.5M | $1.4M | |
Total Current Assets | $2.2B | $1.4B | $796.4M | $274.7M | $205.8M | |
Property Plant And Equipment | $851.3M | $755.2M | $348.4M | $236.9M | $205.1M | |
Long-Term Investments | $401.6M | $273.7M | $420.1M | $100.8M | $24.7M | |
Goodwill | $1.5B | $1.5B | $63.3M | $32M | $32.2M | |
Other Intangibles | $244.1M | $202.4M | $118.8M | $77M | $60.9M | |
Other Long-Term Assets | $4M | $12.3M | $56.6M | $17.9M | $11.4M | |
Total Assets | $5.4B | $4.5B | $1.8B | $962.4M | $641.3M | |
Accounts Payable | $53.3M | $51.5M | $23.5M | $21.2M | $18.2M | |
Accrued Expenses | $13.4M | $14.2M | $4.4M | $4.3M | $1.9M | |
Current Portion Of Long-Term Debt | $7.8M | $7.4M | $411.7M | $76.9M | $3M | |
Current Portion Of Capital Lease Obligations | $33.3M | $30.5M | $21M | $11.2M | $11.6M | |
Other Current Liabilities | $64.2M | $38.5M | $104.4M | $33.3M | $10.7M | |
Total Current Liabilities | $225.2M | $170.8M | $594.3M | $173.7M | $66M | |
Long-Term Debt | $1.2B | $1.2B | $554.5M | $365.1M | $209.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.5B | $1.6B | $1.2B | $591.9M | $300.8M | |
Common Stock | $5.7B | $6B | $5.9B | $6.1B | $6.1B | |
Other Common Equity Adj | -$27.1M | -$33.9M | -$10.2M | -$11.9M | $373.8K | |
Common Equity | $2.8B | $2.9B | $560.7M | $370.3M | $340.4M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $110.9M | $29.5M | $1.2M | $102.9K | -- | |
Total Equity | $2.9B | $2.9B | $561.9M | $370.4M | $340.4M | |
Total Liabilities and Equity | $5.4B | $4.5B | $1.8B | $962.4M | $641.3M | |
Cash and Short Terms | $1.8B | $1.1B | $571.7M | $150.6M | $91.9M | |
Total Debt | $1.3B | $1.2B | $966.2M | $442M | $212.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $914.7M | $621.6M | $493.6M | $126M | $79.5M | |
Short Term Investments | $906.7M | $477.1M | $78M | $24.5M | $12.3M | |
Accounts Receivable, Net | $53.2M | $54.6M | $30.5M | $33.3M | $33.2M | |
Inventory | $291.5M | $163.8M | $61.5M | $57.2M | $67.3M | |
Prepaid Expenses | $38.2M | $26.9M | $10.5M | $6.7M | $3.9M | |
Other Current Assets | $15.1M | $15.3M | $7.5M | $10.5M | $1.4M | |
Total Current Assets | $2.2B | $1.4B | $796.4M | $274.7M | $205.8M | |
Property Plant And Equipment | $851.3M | $755.2M | $348.4M | $236.9M | $205.1M | |
Long-Term Investments | $401.6M | $273.7M | $420.1M | $100.8M | $24.7M | |
Goodwill | $1.5B | $1.5B | $63.3M | $32M | $32.2M | |
Other Intangibles | $244.1M | $202.4M | $118.8M | $77M | $60.9M | |
Other Long-Term Assets | $4M | $12.3M | $56.6M | $17.9M | $11.4M | |
Total Assets | $5.4B | $4.5B | $1.8B | $962.4M | $641.3M | |
Accounts Payable | $53.3M | $51.5M | $23.5M | $21.2M | $18.2M | |
Accrued Expenses | $13.4M | $14.2M | $4.4M | $4.3M | $1.9M | |
Current Portion Of Long-Term Debt | $7.8M | $7.4M | $411.7M | $76.9M | $3M | |
Current Portion Of Capital Lease Obligations | $33.3M | $30.5M | $21M | $11.2M | $11.6M | |
Other Current Liabilities | $64.2M | $38.5M | $104.4M | $33.3M | $10.7M | |
Total Current Liabilities | $225.2M | $170.8M | $594.3M | $173.7M | $66M | |
Long-Term Debt | $1.2B | $1.2B | $554.5M | $365.1M | $209.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.5B | $1.6B | $1.2B | $591.9M | $300.8M | |
Common Stock | $5.7B | $6B | $5.9B | $6.1B | $6.1B | |
Other Common Equity Adj | -$27.1M | -$33.9M | -$10.2M | -$11.9M | $373.8K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $110.9M | $29.5M | $1.2M | $102.9K | -- | |
Total Equity | $2.9B | $2.9B | $561.9M | $370.4M | $340.4M | |
Total Liabilities and Equity | $5.4B | $4.5B | $1.8B | $962.4M | $641.3M | |
Cash and Short Terms | $1.8B | $1.1B | $571.7M | $150.6M | $91.9M | |
Total Debt | $1.3B | $1.2B | $966.2M | $442M | $212.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.3B | -$206.5M | -$2.3B | -$358.5M | -$433.8M | |
Depreciation & Amoritzation | $96.2M | $88.5M | $60.5M | $39.4M | $31M | |
Stock-Based Compensation | $69M | $37.2M | $19.2M | $10.5M | -$3M | |
Change in Accounts Receivable | -$9.1M | $12.9M | $4.7M | -$2.8M | -$3.2M | |
Change in Inventories | $17.5M | $162.9M | $51.8M | $766.4K | -$12.7M | |
Cash From Operations | -$352.6M | -$435.3M | -$421.7M | -$209M | -$119M | |
Capital Expenditures | $131.8M | $38.4M | $7.9M | $3M | $8.1M | |
Cash Acquisitions | $5.3M | $82.3M | $11.3M | -$707.8K | -$5M | |
Cash From Investing | -$669.3M | $184.1M | $327.8M | $179.1M | -$34.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $676.2M | -- | $102.2M | -- | $49M | |
Long-Term Debt Repaid | -$11.8M | -$40.5M | -$89.4M | -$377.8M | -$207.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$11.2M | -$2.4M | -$28.7M | -$26.9M | -$17.6M | |
Cash From Financing | $957.5M | -$36.3M | -$14.9M | -$344.7M | $106.8M | |
Beginning Cash (CF) | $986.6M | $921M | $587M | $501.8M | $122.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$64.4M | -$287.6M | -$108.8M | -$374.6M | -$46.6M | |
Ending Cash (CF) | $874.1M | $618.9M | $512.1M | $126.2M | $81.7M | |
Levered Free Cash Flow | -$484.4M | -$473.7M | -$429.6M | -$211.9M | -$127.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$456M | -$411.3M | -$495M | -$72.7M | -$161.3M | |
Depreciation & Amoritzation | $20.9M | $21.9M | $15.8M | $8.6M | $8.4M | |
Stock-Based Compensation | $13.3M | $8.8M | $3.8M | $3.1M | -$13.4M | |
Change in Accounts Receivable | $516.9K | $9.6M | -$5M | $7.8M | -$967.5K | |
Change in Inventories | $19.7M | $157.6M | $51.8M | $6.7M | -$3.5M | |
Cash From Operations | -$70.3M | -$102.8M | -$114.1M | -$18.1M | -$24.6M | |
Capital Expenditures | $20.4M | $5.7M | $2.4M | $85.2K | $2.3M | |
Cash Acquisitions | -$71.9K | $86M | $2.1M | $2M | -$40K | |
Cash From Investing | -$416.9M | $240.5M | $75.9M | $30.6M | -$987.3K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $676.2M | -- | -- | -- | $391.6K | |
Long-Term Debt Repaid | -$1.6M | -$648.7K | -$2.6M | -$25.2M | -$101.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$10.8M | -$13.7K | -$7.3M | -$6.9M | -$3.4M | |
Cash From Financing | $751M | $445.4K | $92.5M | $3.1M | -$10.5M | |
Beginning Cash (CF) | $633M | $488M | $440.4M | $104.9M | $115.3M | |
Foreign Exchange Rate Adjustment | -$9.3M | -$12.1M | $1.7M | $1.2M | $1.5M | |
Additions / Reductions | $263.8M | $138.1M | $54.3M | $15.7M | -$36.1M | |
Ending Cash (CF) | $874.1M | $618.9M | $512.1M | $126.2M | $81.7M | |
Levered Free Cash Flow | -$90.7M | -$108.5M | -$116.6M | -$18.2M | -$26.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.3B | -$206.5M | -$2.3B | -$358.5M | -$433.8M | |
Depreciation & Amoritzation | $96.2M | $88.5M | $60.5M | $39.4M | $31M | |
Stock-Based Compensation | $69M | $37.2M | $19.2M | $10.5M | -$3M | |
Change in Accounts Receivable | -$9.1M | $12.9M | $4.7M | -$2.8M | -$3.2M | |
Change in Inventories | $17.5M | $162.9M | $51.8M | $766.4K | -$12.7M | |
Cash From Operations | -$352.6M | -$435.3M | -$421.7M | -$209M | -$119M | |
Capital Expenditures | $131.8M | $38.4M | $7.9M | $3M | $8.1M | |
Cash Acquisitions | $5.3M | $82.3M | $11.3M | -$707.8K | -$5M | |
Cash From Investing | -$669.3M | $184.1M | $327.8M | $179.1M | -$34.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $676.2M | -- | -- | -- | $49M | |
Long-Term Debt Repaid | -$11.8M | -$40.5M | -$89.4M | -$377.8M | -$207.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$11.2M | -$2.4M | -$28.7M | -$26.9M | -$17.6M | |
Cash From Financing | $957.5M | -$36.3M | -$14.9M | -$344.7M | $106.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$64.4M | -$287.6M | -$108.8M | -$374.6M | -$46.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$484.4M | -$473.7M | -$429.6M | -$211.9M | -$127.1M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$206.5M | -$2.3B | -$358.5M | -$433.8M | -- | |
Depreciation & Amoritzation | $88.5M | $60.5M | $39.4M | $31M | -- | |
Stock-Based Compensation | $37.2M | $19.2M | $10.5M | -$3M | -- | |
Change in Accounts Receivable | $12.9M | $4.7M | -$2.8M | -$3.2M | -- | |
Change in Inventories | $162.9M | $51.8M | $766.4K | -$12.7M | -- | |
Cash From Operations | -$435.3M | -$421.7M | -$209M | -$119M | -- | |
Capital Expenditures | $38.4M | $7.9M | $3M | $8.1M | -- | |
Cash Acquisitions | $82.3M | $11.3M | -$707.8K | -$5M | -- | |
Cash From Investing | $184.1M | $327.8M | $179.1M | -$34.3M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $49M | -- | |
Long-Term Debt Repaid | -$40.5M | -$89.4M | -$377.8M | -$207.6M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.4M | -$28.7M | -$26.9M | -$17.6M | -- | |
Cash From Financing | -$36.3M | -$14.9M | -$344.7M | $106.8M | -- | |
Beginning Cash (CF) | $2.5B | $2.2B | $1.2B | $547.5M | -- | |
Foreign Exchange Rate Adjustment | -$14.5M | $33.9M | -$957.6K | $6M | -- | |
Additions / Reductions | -$287.6M | -$108.8M | -$374.6M | -$46.6M | -- | |
Ending Cash (CF) | $2.2B | $2.1B | $808.6M | $504.8M | -- | |
Levered Free Cash Flow | -$473.7M | -$429.6M | -$211.9M | -$127.1M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.